PD-1 blockade exhibited a tendency to further decrease KPC tumor growth in Irg1−/− mice but failed to reach statistical significance, even with more proinflammatory TAMs and increased infiltration of CD8+ T cells (fig. The gene discussed is CD8A; the disease is neoplasm.